Alicia Marie Jackson
Chief Executive Officer at Evernow, Inc.
Profile
Alicia Marie Jackson is the founder and current CEO of Evernow, Inc., which was founded in 2019.
She is also currently working as a Director at ImmuneBridge, Inc.
Alicia Marie Jackson active positions
Companies | Position | Start |
---|---|---|
Evernow, Inc.
Evernow, Inc. Medical/Nursing ServicesHealth Services Evernow, Inc. provides women health care services. The firm offers hot flashes, weight gain, brain fog, sleep problems, vaginal dryness, mood swings, fatigue, night sweats and urgent peeing services. The company is headquartered in San Francisco, CA. | Chief Executive Officer | 2018-12-31 |
ImmuneBridge, Inc.
ImmuneBridge, Inc. BiotechnologyHealth Technology ImmuneBridge, Inc. is a biotech company that is developing the next generation of allogeneic cellular medicines to make curative cancer therapies accessible to everyone. The company is based in San Francisco, CA and was founded in 2018 by Jesse Cotari and Peretz Partensky. The company is starting with NK cell-based immunotherapies. The company's proprietary expansion technology amplifies cord blood-derived immune stem cells while maintaining full immune multipotency to create a consistent and abundant cellular source for immunotherapies. ImmuneBridge's scientific approach harnesses this expansion technology along with the unique benefits of umbilical cord blood to enable robust screening and selection for the most potent cancer-fighting cells. Peretz Partensky has been the CEO since 2018. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Evernow, Inc.
Evernow, Inc. Medical/Nursing ServicesHealth Services Evernow, Inc. provides women health care services. The firm offers hot flashes, weight gain, brain fog, sleep problems, vaginal dryness, mood swings, fatigue, night sweats and urgent peeing services. The company is headquartered in San Francisco, CA. | Health Services |
ImmuneBridge, Inc.
ImmuneBridge, Inc. BiotechnologyHealth Technology ImmuneBridge, Inc. is a biotech company that is developing the next generation of allogeneic cellular medicines to make curative cancer therapies accessible to everyone. The company is based in San Francisco, CA and was founded in 2018 by Jesse Cotari and Peretz Partensky. The company is starting with NK cell-based immunotherapies. The company's proprietary expansion technology amplifies cord blood-derived immune stem cells while maintaining full immune multipotency to create a consistent and abundant cellular source for immunotherapies. ImmuneBridge's scientific approach harnesses this expansion technology along with the unique benefits of umbilical cord blood to enable robust screening and selection for the most potent cancer-fighting cells. Peretz Partensky has been the CEO since 2018. | Health Technology |
- Stock Market
- Insiders
- Alicia Marie Jackson